Brief: Fda Approves Zevra's Miplyffa

Zevra Therapeutics

20/09/2024 15:12

Sept 20 (Reuters) - FDA:
    * APPROVES FIRST TREATMENT FOR NIEMANN-PICK DISEASE, TYPE C
    * MIPLYFFA,IN COMBINATION WITH THE ENZYME INHIBITOR
MIGLUSTAT
APPROVED TO TREAT NEUROLOGICAL SYMPTOMS IN NPC PATIENTS AGED 2
&OLDER
    * GRANTED APPROVAL OF MIPLYFFA TO ZEVRA


 ((Reuters.Briefs@thomsonreuters.com;;))